학술논문

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer
Document Type
Article
Source
In: Scientific Reports. (Scientific Reports, December 2023, 13(1))
Subject
Language
English
ISSN
20452322